BOI logo

Boiron SA Stock Price

ENXTPA:BOI Community·€461.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

BOI Share Price Performance

€26.60
-5.85 (-18.03%)
€26.60
-5.85 (-18.03%)
Price €26.60

BOI Community Narratives

There are no narratives available yet.

Recent BOI News & Updates

Earnings Tell The Story For Boiron SA (EPA:BOI)

Sep 10
Earnings Tell The Story For Boiron SA (EPA:BOI)

There May Be Some Bright Spots In Boiron's (EPA:BOI) Earnings

May 06
There May Be Some Bright Spots In Boiron's (EPA:BOI) Earnings

Boiron (EPA:BOI) Is Reducing Its Dividend To €1.20

Apr 18
Boiron (EPA:BOI) Is Reducing Its Dividend To €1.20

Market Participants Recognise Boiron SA's (EPA:BOI) Earnings

Nov 23
Market Participants Recognise Boiron SA's (EPA:BOI) Earnings

Boiron SA Key Details

€504.9m

Revenue

€132.7m

Cost of Revenue

€372.1m

Gross Profit

€352.8m

Other Expenses

€19.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
1.12
Gross Margin
73.71%
Net Profit Margin
3.84%
Debt/Equity Ratio
2.1%

Boiron SA Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet and fair value.

3 Risks
2 Rewards

About BOI

Founded
1932
Employees
2736
CEO
Pascal Houdayer
WebsiteView website
www.boiron.fr

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

French Market Performance

  • 7 Days: 2.5%
  • 3 Months: 3.4%
  • 1 Year: 4.9%
  • Year to Date: 7.5%
Over the last 7 days, the market has risen 3.0%, driven by gains of 5.8% in the Consumer Discretionary sector. Meanwhile, the Energy sector has underperformed, shrinking 4.9% in that time. In the last year, the market has climbed 5.4%. Earnings are forecast to grow by 12% annually. Market details ›